{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T00:47:22Z","timestamp":1661474842118},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2009,3,25]],"date-time":"2009-03-25T00:00:00Z","timestamp":1237939200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0005002","type":"journal-article","created":{"date-parts":[[2009,3,25]],"date-time":"2009-03-25T05:48:18Z","timestamp":1237960098000},"page":"e5002","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Nonadherence to Primary Prophylaxis against Pneumocystis jirovecii Pneumonia"],"prefix":"10.1371","volume":"4","author":[{"given":"James D.","family":"Heffelfinger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew C.","family":"Voetsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenn V.","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick S.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. D.","family":"McNaghten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2009,3,25]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1086\/313843","article-title":"Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy.","volume":"30","author":"JE Kaplan","year":"2000","journal-title":"Clin Infect Dis"},{"key":"ref2","first-page":"466","article-title":"Projecting the medical costs of AIDS and ARC in the United States.","volume":"1","author":"JW Hay","year":"1988","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.3201\/eid1010.030985","article-title":"Current epidemiology of Pneumocystis pneumonia.","volume":"10","author":"A Morris","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1001\/jama.259.8.1185","article-title":"Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS.","volume":"259","author":"MA Fischl","year":"1988","journal-title":"JAMA"},{"key":"ref5","article-title":"HIV\/AIDS Surveillance Report, 1989","year":"1990"},{"key":"ref6","article-title":"HIV\/AIDS Surveillance Report, 1992","year":"1993"},{"key":"ref7","first-page":"1","article-title":"Guidelines for preventing opportunistic infections among HIV-infected persons\u20132002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America.","volume":"51","author":"JE Kaplan","year":"2002","journal-title":"MMWR Recomm Rep"},{"key":"ref8","article-title":"Healthy People 2010: understanding and improving health. 2nd ed. 2000","year":"2000"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1086\/511862","article-title":"Reasons for lack of appropriate receipt of primary Pneumocystis jiroveci pneumonia prophylaxis among HIV-infected persons receiving treatment in the United States: 1994\u20132003.","volume":"44","author":"EH Teshale","year":"2007","journal-title":"Clin Infect Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/00126334-199907010-00008","article-title":"Adherence to guidelines for antiretroviral therapy and for preventing opportunistic infections in HIV-infected adults and adolescents in Ryan White-funded facilities in the United States.","volume":"21","author":"JE Kaplan","year":"1999","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1097\/00002030-200011100-00019","article-title":"Epidemiology of Pneumocystis carinii pneumonia in an era of effective prophylaxis: the relative contribution of non-adherence and drug failure.","volume":"14","author":"BE Lundberg","year":"2000","journal-title":"AIDS"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00042560-199806010-00003","article-title":"Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease.","volume":"18","author":"LJ Eldred","year":"1998","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"ref13","first-page":"133","article-title":"The supplement to HIV-AIDS Surveillance project: an approach for monitoring HIV risk behaviors.","volume":"111","author":"JW Buehler","year":"1996","journal-title":"Public Health Rep"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1111\/j.1521-0391.2003.tb00493.x","article-title":"Alcohol use disorders: screening and diagnosis.","volume":"12","author":"SA Maisto","year":"2003","journal-title":"Am J Addict"},{"key":"ref15","article-title":"Categorical Data Analysis. (Second edition).","author":"A Agresti","year":"2002"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1176\/appi.psy.45.5.394","article-title":"Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons.","volume":"45","author":"A Ammassari","year":"2004","journal-title":"Psychosomatics"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s11606-002-0044-3","article-title":"Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users.","volume":"17","author":"JH Arnsten","year":"2002","journal-title":"J Gen Intern Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1525-1497.2004.30445.x","article-title":"Gender differences in factors associated with adherence to antiretroviral therapy.","volume":"19","author":"KM Berg","year":"2004","journal-title":"J Gen Intern Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1097\/00002030-200211080-00010","article-title":"A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women.","volume":"16","author":"AA Howard","year":"2002","journal-title":"AIDS"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1258\/0956462011924290","article-title":"Factors affecting adherence and convenience in antiretroviral therapy.","volume":"12","author":"A Lafeuillade","year":"2001","journal-title":"Int J STD AIDS"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1023\/B:EJEP.0000032353.03967.ef","article-title":"Illicit drug use: can it predict adherence to antiretroviral therapy?","volume":"19","author":"M Martini","year":"2004","journal-title":"Eur J Epidemiol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1086\/424008","article-title":"Adherence to highly active antiretroviral therapy in the homeless population in San Francisco: a prospective study.","volume":"39","author":"AR Moss","year":"2004","journal-title":"Clin Infect Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e552","DOI":"10.1371\/journal.pone.0000552","article-title":"Patient and regimen characteristics associated with self-reported nonadherence to antiretroviral therapy.","volume":"2","author":"PS Sullivan","year":"2007","journal-title":"PLoS ONE"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/01.qai.0000186364.27587.0e","article-title":"Factors associated with nonadherence to highly active antiretroviral therapy: a 5-year follow-up analysis with correction for the bias induced by missing data in the treatment maintenance phase.","volume":"41","author":"MP Carrieri","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1097\/00002030-199909100-00021","article-title":"Sociodemographic and psychological variables influencing adherence to antiretroviral therapy.","volume":"13","author":"V Gordillo","year":"1999","journal-title":"AIDS"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"S136","DOI":"10.1097\/00126334-200212153-00010","article-title":"Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy.","volume":"31","author":"F Starace","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0002-9343(92)90746-X","article-title":"Compliance with zidovudine therapy in patients infected with human immunodeficiency virus, type 1: a cross-sectional study in a municipal hospital clinic.","volume":"92","author":"JH Samet","year":"1992","journal-title":"Am J Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1161\/01.HYP.2.6.757","article-title":"Can simple clinical measurements detect patient noncompliance?","volume":"2","author":"RB Haynes","year":"1980","journal-title":"Hypertension"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1164\/ajrccm\/147.5.1311","article-title":"When tuberculosis treatment fails. A social behavioral account of patient adherence.","volume":"147","author":"E Sumartojo","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0021-9681(79)90012-2","article-title":"Bias in analytic research.","volume":"32","author":"DL Sackett","year":"1979","journal-title":"J Chronic Dis"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/j.1525-1497.2004.30248.x","article-title":"Patient-reported and physician-estimated adherence to HAART: social and clinic center-related factors are associated with discordance.","volume":"19","author":"R Murri","year":"2004","journal-title":"J Gen Intern Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00042560-200109010-00008","article-title":"Trust and the acceptance of and adherence to antiretroviral therapy.","volume":"28","author":"FL Altice","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1046\/j.1525-1497.2002.00746.x","article-title":"HIV-seropositive individuals' optimistic beliefs about prognosis and relation to medication and safe sex adherence.","volume":"17","author":"WC Holmes","year":"2002","journal-title":"J Gen Intern Med"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0005002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T15:20:38Z","timestamp":1589037638000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0005002"}},"subtitle":[],"editor":[{"given":"Ben","family":"Marais","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2009,3,25]]},"references-count":33,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2009,3,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0005002","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,25]]}}}